Denmark vs Latvia: Previously treated cases tested for RR-/MDR-TB
Denmark
81.0%
in 2024
Latvia
80.0%
in 2022
Denmark rank
111th
Latvia rank
114th
Previously treated cases tested for RR-/MDR-TB over time
- Denmark
- Latvia
How they compare
Denmark currently reports 81.0% against 80.0% in Latvia, a difference of 1.0%.
The two have swapped places 1 time across 15 shared years of data; in 2005 it was Latvia ahead.
Denmark ranks 111th and Latvia ranks 114th of 180 countries.
Across the 3 decades both report, Denmark averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Denmark | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.0% | 92.4% | 25.4% | Latvia |
| 2010s | 69.9% | 88.1% | 18.2% | Latvia |
| 2020s | 89.5% | 86.0% | 3.5% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Denmark or Latvia?
- Denmark, at 81.0% against 80.0% in Latvia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Denmark and Latvia?
- 1.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Latvia?
- 15 years are reported by both, from 2005 to 2022.
- How do Denmark and Latvia rank globally for previously treated cases tested for rr-/mdr-tb?
- Denmark ranks 111th and Latvia ranks 114th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.